Supreme Court to Address “Pay for Delay” Model
The Supreme Court announced earlier this month their intention to investigate a multibillion-dollar dispute between the pharmaceutical industry and federal antitrust enforcers. The practice in question is commonly referred to as the “pay-for-delay” model, whereby brand-name drug manufacturers compensate other manufacturers to hold off on selling generic versions of their drug.
AHIP Fall Forum 2012 Recap
The America’s Health Insurance Plans Fall Forum 2012 conference took place in Chicago, IL, from December 3-5. Here are some of the highlights from the conference.